3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
28
NIH
3
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hodgkin Disease
1
Interventions
Vinorelbine
3
Gemcitabine
3
Ifosfamide
2
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
fludarabine phosphate
1
fludarabine
1
entecavir
1
Thiotepa
1
Rituximab
1
Platelet Transfusion
1
Mind-Body Therapies
1
Etoposide
1
Drug Therapy
1
Dietary Supplements
1
Cytarabine
1
Cyclophosphamide
1
Acupuncture Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Lymphoma
×
Thiotepa
×
Clear all
NCT03346096
2024-07-09
TEAM
Sheba Medical Center
Phase 2
Completed
50 enrolled